Covisint Corp Balance Sheet | Understand Stock

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q4 FY2017 As of Mar 31, 2017	Q3 FY2017 As of Dec 31, 2016	Q2 FY2017 As of Sep 30, 2016	Q1 FY2017 As of Jun 30, 2016	Q4 FY2016 As of Mar 31, 2016	Q3 FY2016 As of Dec 31, 2015	Q2 FY2016 As of Sep 30, 2015	Q1 FY2016 As of Jun 30, 2015	Q4 FY2015 As of Mar 31, 2015	Q3 FY2015 As of Dec 31, 2014	Q2 FY2015 As of Sep 30, 2014	Q1 FY2015 As of Jun 30, 2014	Q4 FY2014 As of Mar 31, 2014	Q3 FY2014 As of Dec 31, 2013	Q2 FY2014 As of Sep 30, 2013
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
Initial public offering proceeds receivable
Accounts receivable, net of allowance for doubtful accounts of $36 and $39 as of March 31, 2017 and 2016, respectively
Deferred tax asset, net
Due from parent and affiliates
Prepaid expenses
Other current assets
Total current assets

PROPERTY AND EQUIPMENT, NET
CAPITALIZED SOFTWARE AND OTHER INTANGIBLE ASSETS, NET
OTHER:
Goodwill
Deferred costs
Deferred tax asset, net
Other assets
Total other assets
TOTAL ASSETS
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable
Accrued commissions and bonuses
Deferred revenue
Accrued expenses
Due to parent and affiliates
Total current liabilities
DEFERRED REVENUE
ACCRUED LIABILITIES
DEFERRED TAX LIABILITY, NET
Total liabilities
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS' EQUITY:
Preferred stock, no par value - authorized 5,000,000 shares; none issued and outstanding
Common stock, no par value - authorized 50,000,000 shares; issued and outstanding 40,865,897 and 40,490,928 as of March 31, 2017 and 2016, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total shareholders' equity
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

Comments